Introduction

ki:elements pioneers speech-based biomarkers as tools for clinical research. We are seeking a strategic and commercially minded Therapeutic Area Lead to guide the development, positioning, and market success of SB-C, our speech biomarker for cognition.

Tasks

This role combines product ownership with commercial leadership — shaping the vision, driving adoption, and acting as the trusted external champion of SB-C across the Alzheimer’s disease and cognitive health ecosystem.

You will own the end-to-end strategy for SB-C: from defining the product roadmap and market fit to leading external engagement with pharma and biotech partners. You will be the bridge between science, product, and business — ensuring SB-C continues to advance as the industry’s most trusted digital cognitive assessment.

• Define and own the strategic vision and roadmap for SB-C within Alzheimer’s disease and related cognitive disorders.
• Work closely with R&D, data science, clinical, and regulatory teams to align technical development with customer and market needs.
• Translate market insights and clinical developments into product requirements and value propositions.
• Guide evidence-generation and validation strategies to strengthen product credibility and differentiation.
• Act as the primary commercial champion for SB-C — representing the product externally with clients, partners, and industry bodies.
• Build and manage strategic partnerships with pharma, biotech, CROs, and digital health collaborators deploying SB-C.
• Lead go-to-market planning, pricing strategy, and client engagement approaches.
• Support business development by articulating the clinical and commercial value of SB-C to prospective partners.
• Monitor competitive landscape and market trends in AD and digital biomarkers to identify growth opportunities.
• Serve as a trusted expert in cognition and Alzheimer’s disease, supporting client implementation and ensuring scientific credibility.
• Collaborate cross-functionally across the organization to drive alignment and impact.
• Represent SB-C at key scientific and industry events, publications, and collaborations.

Requirements

• Advanced degree in neuroscience, psychology, pharmacology, or a related field; MBA or equivalent commercial experience is an asset.
• Between 5 and 15 years of expertise in Alzheimer’s disease drug development, cognitive assessment, or biomarker strategy, ideally with product or commercial exposure.
• Deep understanding of cognition, clinical endpoints, and the evolving biomarker landscape in neurodegenerative diseases.
• Strategic thinker with strong commercial acumen.
• Excellent communication and relationship-building skills.
• Comfortable operating at the interface of science and business.
• Experience engaging pharma or biotech partners is highly desirable.
• Up to 30% travel.

Benefits

• ki:elements offers a four-day workweek (100% = 32 hours; Mo-Th)
• Remote (Europe & US East Coast preferred) or at our offices in Berlin & Saarbrücken.
• Be part of a pioneering company at the forefront of healthcare innovation.
• Work with a talented and passionate team dedicated to making a difference.
• 85.000€ - 120.000€ in full time (100%); part-time equivalent.

Contact

If our profiles match, we would be delighted to hear from you. Please contact us with your resume and a brief note why we should work together in the future.